What is the best GHRP and GHRH stack?

Ipamorelin paired with CJC-1295 (No DAC) is a common GH stack. Ipamorelin drives GH release via ghrelin pathways while CJC-1295 (No DAC) supports pulse amplification via GHRH signaling.

Can you stack BPC-157 and TB-500?

Yes. BPC-157 and TB-500 are frequently combined for recovery-oriented protocols because their effects are generally considered complementary.

Can you combine two GLP-1 peptides like semaglutide and tirzepatide?

No. Combining two GLP-1-pathway agents is generally avoided due to overlapping mechanism and higher adverse-effect risk without clear additive benefit.

Is the stack checker data private?

Yes. Stack analysis runs client-side in your browser. No stack selections are transmitted to our servers.

Peptide Stack Checker

Analyze pairwise compatibility for 2–3 peptide combinations with practical guidance for synergy and storage.

No data collected — all stack selections remain in your browser.

Research disclaimer: Compatibility ratings are based on mechanistic plausibility and research-community convention. These specific combinations are not validated by clinical stack trials.

Build Your Stack (2–3 Peptides)

Select peptides to analyze pairwise synergy, risk, and storage guidance.

Search peptides

No peptides selected yet.

0/3 selected

Popular Stacks

Quick-start combinations frequently searched by the research community.

BPC-157 + TB-500

Preset

Recovery-focused pairing often discussed for connective tissue support.

Ipamorelin + CJC-1295 (No DAC)

Preset

Classic GH-optimization pairing with complementary signaling.

Selank + Semax

Preset

Popular cognitive stack for focus and mood-oriented research.

Epitalon + Thymalin

Preset

Bioregulator combination often used in longevity discussions.

Semaglutide + BPC-157

Preset

Frequently discussed for metabolic + GI support objectives.

GHK-Cu + Epitalon

Preset

Aging-focused stack with skin/tissue and longevity angle.

Methodology & Evidence Basis

Compatibility ratings are based on mechanistic plausibility (receptor pathway overlap, known pharmacodynamic interactions) and research-community convention. These specific combinations have not been validated in clinical stack trials.

Storage recommendations in stack results use the same first-order discrete decay model as the main calculator: P(t) = 100 × (1 − r)^t, per ICH Q1A(R2). Decay rates are internal model estimates [Model Estimate — PeptideClock].

Sources:

• ICH Q1A(R2) — Pharmaceutical stability testing framework (EMA/FDA)
• Waterman & Adami, Int J Pharm 2005 (PMID 15778049) — Arrhenius stability model
• ICH Q5C — Stability guidelines for biological products